Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | ANDIA, MARCELO E. |
| Género | Hombre |
| Área Principal WOS | Biology; Radiology, Nuclear Medicine & Medical Imaging; Medicine, Research & Experimental; |
| Afiliación Principal | Pontificia Universidad Católica De Chile |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Biology | 1 |
| Radiology, Nuclear Medicine & Medical Imaging | 1 |
| Medicine, Research & Experimental | 1 |
| Spectroscopy | 1 |
| Biophysics | 1 |
| Scopus | #Pub |
|---|
| SciELO | #Pub |
|---|
| Autor | Género | # Pub |
|---|---|---|
| XAVIER, A. | Mujer | 1 |
| TOLEDO-RIVERA, CAMILO ENRIQUE | Hombre | 1 |
| DIAZ, HUGO S. | Hombre | 1 |
| ARRESE-JIMENEZ, MARCO ANTONIO | Hombre | 1 |
| SING-LONG, C. A. | Hombre | 1 |
| PEREYRA, KATHERIN | - | 1 |
| DIAZ-JARA, ESTEBAN | Hombre | 1 |
| GONZALEZ, LETICIA | Mujer | 1 |
| BRAVO, LIENA | Mujer | 1 |
| SCHWARZ, KARLA G. | Mujer | 1 |
| FLORES, MARIAJOSÉ | - | 1 |
| DEL RIO, RODRIGO | Hombre | 1 |
| BOTNAR, RENEPRIME M. | Hombre | 1 |
| Título | Año | Citas | Tipo | Revista | Indexada |
|---|---|---|---|---|---|
| Characterization Of Hepatic Fatty Acids Using Magnetic Resonance Spectroscopy For The Assessment Of Treatment Response To Metformin In An E Nos−/− Mouse Model Of Metabolic Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis | 2023 | 0 | artículo de investigación | Nmr In Biomedicine | WoS Scopus |
| Enhanced Peripheral Chemoreflex Drive Is Associated With Cardiorespiratory Disorders In Mice With Coronary Heart Disease | 2023 | 0 | proceedings paper | Advances In Experimental Medicine And Biology | WoS Scopus |
| Palabra Clave | #Pub |
|---|---|
| hypomorphic | 1 |
| visceral fat | 1 |
| thin-layer chromatography | 1 |
| sympathetic-nervous-system | 1 |
| scavenger receptor class b type 1 | 1 |
| risk-factors | 1 |
| obese | 1 |
| nitric-oxide | 1 |
| natural-history | 1 |
| nafld progression | 1 |
| nafld | 1 |
| myocardial-infarction | 1 |
| mri | 1 |
| metformin | 1 |
| mechanisms | 1 |
| management | 1 |
| adipose-tissue | 1 |
| failure | 1 |
| enos−/− | 1 |
| enos(- -) | 1 |
| disease | 1 |
| deficient | 1 |
| coronary heart disease | 1 |
| chemosensitivity | 1 |
| carotid-body | 1 |
| carotid body | 1 |
| cardiac dysfunction | 1 |
| burden | 1 |
| atherosclerosis | 1 |
| apoliprotein e | 1 |
| animal-models | 1 |